EUVIMEDEUVIMED entdecken
Crossref

A linear model‐based, B 1 inhomogeneity–corrected, glutamate‐weighted chemical exchange saturation transfer MRI at 5 T

Hao Tang, Hao Chen, Qiting Wu, Ying Liu, Dawei Yin, Runyu Tang, Xiaopeng Song, Bingsheng Huang, Dong Liang iD, Hairong Zheng iD, Yin Wu iD

Magnetic Resonance in Medicine · 2026

DOI: 10.1002/mrm.70118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Hao Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Brain Neoplasms, Glutamic Acid, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glutamate‐weighted chemical exchange saturation transfer (gluCEST) MRI shows promise in the diagnosis and evaluation of neurological disorders. GluCEST must be conducted at high magnetic field strengths, in which pronounced B 1 inhomogeneity compromises gluCEST measurements. Conventional B 1 inhomogeneity correction methods rely on interpolation algorithms, B 1 choices, acquisition numbers, or calibration curves, making correction unrobust. This study proposes a linear model‐based method for B 1 inhomogeneity correction in gluCEST MRI.

Methods

Four healthy volunteers and 4 brain‐tumor patients underwent B 1 field mapping and chemical exchange saturation transfer (CEST) imaging at three nominal B 1 levels of 3.5, 4.0, and 4.5 μT at 5 T. The linear relationship between 1/Z(±3 ppm) and B 1 was investigated using numerical simulations and human‐brain data. The 1/Z(±3 ppm) values at nominal B 1 were calculated based on the linear function constructed from either two or three CEST acquisitions. GluCEST signals, quantified with 1‐Z(+3 ppm)/Z(−3 ppm), were compared before and after B 1 inhomogeneity correction, including those corrected with the conventional interpolation method.

Results

A linear dependency of 1/Z(±3 ppm) on B 1 within a B 1 range of 2–5 μT was identified. Evident B 1 inhomogeneity artifacts were observed in the uncorrected gluCEST images. GluCEST signals corrected using the conventional interpolation method varied with CEST acquisition numbers, particularly in regions with severe B 1 inhomogeneity. In contrast, the linear model yielded consistent gluCEST contrasts with less dependence on CEST acquisition numbers, superior to the interpolation method.

Conclusion

The proposed linear model allows robust B 1 inhomogeneity correction from at least two CEST acquisitions, providing an effective way for improved gluCEST MRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingBrain NeoplasmsGlutamic AcidImage Processing, Computer-AssistedHumansBrainAlgorithmsAdultLinear ModelsMaleFemaleHealthy VolunteersMiddle AgedComputer SimulationReproducibility of ResultsImage Interpretation, Computer-Assisted

Stichwörter der Autor:innen

B1 inhomogeneitychemical exchange saturation transferglutamatetumor

Substanzen

Glutamic Acid

Autor:innen und Institutionen

  • Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China.
  • School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, China.
  • Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, China.
  • Collaborative Innovation Department, Shanghai United Imaging Healthcare Co., Ltd., Shanghai, China.
  • Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, China.
  • State Key Laboratory of Biomedical Imaging Science and System, China.

ORCID-Profile: Dong Liang, Hairong Zheng, Yin Wu

Förderung

  • National Natural Science Foundation of China
  • Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province
  • Shenzhen Science and Technology Program

Zitieren

APA

Tang, H., Chen, H., Wu, Q., Liu, Y., Yin, D., Tang, R., Song, X., Huang, B., Liang, D., Zheng, H., & Wu, Y. (2026). A linear model‐based, B 1 inhomogeneity–corrected, glutamate‐weighted chemical exchange saturation transfer MRI at 5 T. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70118

Vancouver

Tang H, Chen H, Wu Q, Liu Y, Yin D, Tang R, et al. A linear model‐based, B 1 inhomogeneity–corrected, glutamate‐weighted chemical exchange saturation transfer MRI at 5 T. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70118

BibTeX
@article{Tang2026,
  author = {Tang, Hao and Chen, Hao and Wu, Qiting and Liu, Ying and Yin, Dawei and Tang, Runyu and Song, Xiaopeng and Huang, Bingsheng and Liang, Dong and Zheng, Hairong and Wu, Yin},
  title = {A linear model‐based, B 1 inhomogeneity–corrected, glutamate‐weighted chemical exchange saturation transfer MRI at 5 T},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  doi = {10.1002/mrm.70118}
}
Kostenlos starten →